Basisstatistiken
Einführung
Dieser Short Interest Tracker bietet eine Vielzahl von Daten zu Leerverkäufen, die von verschiedenen Partnern bezogen werden. Die Daten sind nach Aktualisierungshäufigkeit geordnet, wobei die Intraday-Daten ganz oben stehen (Verfügbarkeit von Short-Aktien, Leihgebührensatz), die täglichen Daten (Short-Volumen, Fail-to-Deliver) in der Mitte und die am langsamsten aktualisierten Daten (Short-Interesse) ganz unten. Beachten Sie, dass die Short-Zinsen zweimal im Monat nach einem von FINRA festgelegten Zeitplan veröffentlicht werden.
Short-Squeeze-Score
Der-Short-Squeeze Score ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit dem höchsten Risiko für einen Short-Squeeze identifiziert. Das Scoring-Modell verwendet eine Kombination aus Short-Zinsen, Streubesitz, Short-Leihgebühren und anderen Metriken. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen für ein höheres Risiko eines Short-Squeeze im Vergleich zu den anderen Unternehmen stehen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Innertags
Siehe unsere Short-Squeeze-Ranglisten für die USA, Kanada, Australien and Hongkong
AI+ Ask Fintel’s AI assistant about Alliance Pharma plc.
Select a question to share a public post with an AI-crafted answer.
Funds Disclosing Short Positions - Europe
This section shows European institutions, funds, and major shareholders that have reported short positions in the security.
Upgrade to unlock premium data.
| File Date | Owner | Issuer | ISIN | Total Capitalization Shorted (%) |
|---|---|---|---|---|
| 2025-05-12 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,00 |
| 2025-01-10 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,65 |
| 2024-11-21 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,78 |
| 2024-11-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,83 |
| 2024-11-01 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,72 |
| 2024-10-31 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,54 |
| 2024-08-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,37 |
| 2024-06-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,61 |
| 2024-05-24 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,72 |
| 2024-05-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,87 |
| 2024-03-12 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,98 |
| 2024-02-07 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,45 |
| 2024-02-06 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,55 |
| 2024-02-02 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,67 |
| 2024-02-01 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,03 |
| 2024-01-30 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,88 |
| 2024-01-29 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,96 |
| 2024-01-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,01 |
| 2024-01-04 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,70 |
| 2023-12-20 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,69 |
| 2023-12-14 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,18 |
| 2023-11-16 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,70 |
| 2023-11-07 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,25 |
| 2023-11-06 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,37 |
| 2023-10-20 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,64 |
| 2023-10-13 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,78 |
| 2023-10-10 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,49 |
| 2023-09-26 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,54 |
| 2023-08-24 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,87 |
| 2023-08-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,63 |
| 2023-07-21 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,70 |
| 2023-07-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,63 |
| 2023-07-18 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,52 |
| 2023-05-25 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,70 |
| 2023-05-17 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,46 |
| 2023-04-27 | GLG Partners LP | Alliance Pharma | GB0031030819 | 0,66 |
| 2023-04-19 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,33 |
| 2023-04-05 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,49 |
| 2023-03-29 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,53 |
| 2023-03-23 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,48 |
| 2023-03-22 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,38 |
| 2023-03-17 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,12 |
| 2023-03-13 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 1,05 |
| 2023-02-22 | BlackRock Investment Management (UK) Limited | Alliance Pharma | GB0031030819 | 0,63 |
| 2022-11-24 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0,00 |
| 2022-11-23 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0,62 |
| 2022-11-10 | JPMorgan Asset Management (UK) Ltd | Alliance Pharma Plc | GB0031030819 | 0,50 |